Pretreatment Dynamic Susceptibility Contrast MRI Perfusion in Glioblastoma: Prediction of EGFR Gene Amplification.
about
Integrative Network-based Analysis of Magnetic Resonance Spectroscopy and Genome Wide Expression in Glioblastoma multiformeBenefits of dynamic susceptibility-weighted contrast-enhanced perfusion MRI for glioma diagnosis and therapy.Emerging treatment strategies for glioblastoma multiformeT1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status.Imaging genomics in cancer research: limitations and promisesMolecular differences between cerebral blood volume and vessel size in glioblastoma multiforme.Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.Mesoscopic imaging of glioblastomas: Are diffusion, perfusion and spectroscopic measures influenced by the radiogenetic phenotype?Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma.Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges.Radiogenomics to characterize regional genetic heterogeneity in glioblastoma.MRI features can predict EGFR expression in lower grade gliomas: A voxel-based radiomic analysis.Non-invasive tumor genotyping using radiogenomic biomarkers, a systematic review and oncology-wide pathway analysis.Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme.Quantification and visualization of lipid landscape in glioma using in -and opposed-phase imaging
P2860
Q28828676-AB957384-0358-4E29-943B-83943C3C868DQ30872679-C02290A5-8CF3-4F7E-A359-192E70CC4E75Q34542656-E3006FDA-108A-412F-AC8E-021AA65A1ABFQ36494583-A1E8CA25-AAA7-4B68-8A39-C6B1141A7050Q37176568-1FD61238-FC41-47F1-9ACF-75925DCD202DQ37706877-F2451163-659B-46AF-80E1-6884E8922D32Q38743138-876CF69C-9836-43D2-9662-9065DE7A4164Q39172977-5BCD66AC-5859-40AC-9F8A-0016923FD846Q40433973-DD4A8045-EDE0-4C01-9AB7-1D2258706AB5Q43376098-FA8CFD0E-1766-4E61-874A-5025ECD70BECQ48582092-48B7F4F8-A1CA-4019-9E87-8B5B3C76C08AQ53136216-1960A41E-ED7C-4C77-BFA5-45342A41A749Q54948216-1E04BD29-783A-4C68-9D38-AA7C935BCBC4Q54970083-B26D7A81-6019-46D5-9421-30D116B0C409Q58796944-88269AC4-E601-42A9-94FD-9936CE202D6B
P2860
Pretreatment Dynamic Susceptibility Contrast MRI Perfusion in Glioblastoma: Prediction of EGFR Gene Amplification.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Pretreatment Dynamic Susceptib ...... on of EGFR Gene Amplification.
@ast
Pretreatment Dynamic Susceptib ...... on of EGFR Gene Amplification.
@en
type
label
Pretreatment Dynamic Susceptib ...... on of EGFR Gene Amplification.
@ast
Pretreatment Dynamic Susceptib ...... on of EGFR Gene Amplification.
@en
prefLabel
Pretreatment Dynamic Susceptib ...... on of EGFR Gene Amplification.
@ast
Pretreatment Dynamic Susceptib ...... on of EGFR Gene Amplification.
@en
P2093
P2860
P50
P1476
Pretreatment Dynamic Susceptib ...... ion of EGFR Gene Amplification
@en
P2093
P2860
P2888
P304
P356
10.1007/S00062-014-0289-3
P577
2014-01-29T00:00:00Z